Nova Taq Hot Start DNA Polymerase

NovaTaq Hot Start DNA Polymerase is a chemically modified Taq DNA Polymerase, which is inactive at room temperature. This polymerase is a derived recombinant form of Thermus aquaticus DNA polymerase. The enzyme exhibits a 5′→3′ DNA polymerase activity and lacks 3′→5′ exonuclease activity. The enzyme provides improved specificity when compared to standard Taq polymerase and can eliminate the presence of nonspecific amplification such as primer-dimers and mis-primed products. The enzyme must be activated by heat treatment (7–10 min at 95°C), after which thermal cycling can proceed. NovaTaq Hot Start DNA Polymerase generates PCR products with 3′-dA overhangs, suitable for cloning with Novagen^® Perfectly Blunt^®, Acceptor, and LIC Vector Kits. NovaTaq Hot Start DNA Polymerase is a component of NovaTaq Hot Start Master Mix Kit.

Source: Recombinant Thermus aquaticus DNA polymerase expressed in E. coli
Concentration: 5.0 U/μl
Endonuclease:None detected
Exonuclease: None detected
Amplification efficiency: Functional PCR
Storage: –20°

NovaTaq Hot Start DNA Polymerase has been used in polymerase chain reaction (PCR) amplification. It is suitable for use in Hot Start routine PCR.

•250 U or 5 × 250 UNovaTaq Hot Start DNA Polymerase (5 U/µl)

•1.5 ml or 5 × 1.5 ml10X NovaTaq Hot Start Buffer•1.5 ml or 5 × 1.5 ml25 mM MgCl₂

Toxicity: Multiple Toxicity Values, refer to MSDS (O)

One unit is defined as the amount of enzyme that will catalyze the incorporation of 10 nmol of dNTP into acid-insoluble form in 30 min at 72°C, in a reaction containing 25 mM TAPS (tris-[hydroxymethyl]-methyl-amino-propane-sulfonic acid, sodium salt), pH 9.3 at 25°C, 50 mM KCl, 2 mM MgCl₂, 1 mM 2-mercaptoethanol, 0.2 mM dATP, dGTP, and dTTP, 0.1 µM [α-³²P]dCTP, and 12.5 µg activated salmon sperm DNA in a volume of 50 µl.

Purchase of this product includes an immunity from suit under patents specified in the product insert to use only the amount purchased for the purchaser′s own internal research. No other patents rights are conveyed expressly, by implication, or by estoppel. Further information on purchasing licenses may be obtained by contacting the Director of Licensing, Applied Biosystems, 850 Lincoln Centre Drive, Foster City, California, 94404, USA.

NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany

Perfectly Blunt is a registered trademark of Merck KGaA, Darmstadt, Germany